Chemosensitization of multidrug resistant Candida albicans by the oxathiolone fused chalcone derivatives

Frontiers in Microbiology

Volumn 6, Issue AUG, 2015, Pages

  Łacka, Izabela ^a   Konieczny, Marek T ^b   Bułakowska, Anita ^b   Kodedová, Marie ^c,e   Gašková, Dana ^c   Maurya, Indresh K ^d   Prasad, Rajendra ^d,f   Milewski, Slawomir ^a  

^a GDANSK UNIVERSITY OF TECHNOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c CHARLES UNIVERSITY   (Czech Republic)

^d JAWAHARLAL NEHRU UNIVERSITY   (India)

^e INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^f AMITY UNIVERSITY HARYANA   (India)

Author keywords

Antifungals; Candida albicans; Chalcones; Chemosensitization; Multidrug resistance

Indexed keywords

1,3 OXATHIOLANE DERIVATIVE; CHALCONE DERIVATIVE; FLUCONAZOLE; RHODAMINE;

ANIMAL CELL; ARTICLE; CANDIDA ALBICANS; CELL MEMBRANE RESISTANCE; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; MULTIDRUG RESISTANCE; NONHUMAN; SENSITIVITY ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84940927655     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.00783     Document Type: Article

References (38)

1. Balzi, E., Chen, W., Ulaszewski, S., Capieaux, E., and Goffeau, A. (1987). The multidrug resistance gene PDR1 from Saccharomyces cerevisiae. J. Biol. Chem. 262, 16871-16879.
2. Cadek, R., Chládková, K., Sigler, K., and Gášková, D. (2004). Impact of the growth phase on the activity of multidrug resistance pumps and membrane potential of S. cerevisiae: effect of pump overproduction and carbon source. Biochim. Biophys. Acta 1665, 111-117. doi: 10.1016/j.bbamem.2004.06.020
3. Clinical Laboratory Standards Institute. (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts-Second Edition. Approved Standard M27-A3. Wayne, PA: CLSI.
4. Conseil, G., Baubichon-Cortay, H., Dayan, G., Jault, J. M., Barron, D., and Di Pietro, A. (1998). Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 95, 9831-9836. doi: 10.1073/pnas.95.17.9831
5. Conseil, G., Decottignies, A., Jault, J. M., Comte, G., Barron, D., Goffeau, A., et al. (2000). Prenyl-flavonoids as potent inhibitors of the Pdr5p multidrug ABC transporter from Saccharomyces cerevisiae. Biochemistry 39, 6910-6917. doi: 10.1021/bi000040f
6. Decottignies, A., Grant, A. M., Nichols, J. W., de Wet, H., McIntosh, D. B., and Goffeau, A. (1998). ATP-ase and multidrug transport activities of overexpressed yeast ABC protein Yor1p. J. Biol. Chem. 273, 12612-12622. doi: 10.1074/jbc.273.20.12612
7. Dimmock, J. R., Elias, D. W., Beazely, M. A., and Kandepu, N. M. (1999). Bioactivities of chalcones. Curr. Med. Chem. 6, 1125-1149.
8. Diwischek, F., Morschhäuser, J., and Holzgrabe, U. (2009). Cerulenin analogues as inhibitors of efflux pumps in drug-resistant Candida albicans. Arch. Pharm. (Weinheim) 342, 150-164. doi: 10.1002/ardp.200800160
9. Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., and Morschhäuser, J. (1998). Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob. Agents Chemother. 42, 3065-3072.
10. Franz, R., Ruhnke, M., and Morschhäuser, J. (1999). Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42, 453-458. doi: 10.1046/j.1439-0507.1999.00498.x
11. Gupta, V., Kohli, A., Krishnamurthy, S., Puri, N., Aalamgeer, S. A., Panwar, S., et al. (1998). Identification of polymorphic mutant alleles of CaMDR1, a major facilitator of C. albicans which confers multidrug resistance and its in vitro transcriptional activation. Curr. Genet. 34, 192-199. doi: 10.1007/s002940050385
12. Hendrych, T., Kodedová, M., Sigler, K., and Gášková, D. (2009). Characterization of the kinetics and mechanisms of inhibition of drugs interacting with the S. cerevisiae multidrug resistance pumps Pdr5p and Snq2p. Biochim. Biophys. Acta 1788, 717-723. doi: 10.1016/j.bbamem.2008.12.001
13. Holmes, A. R., Keniya, M. V., Ivnitski-Steele, I., Monk, B. C., Lamping, E., Sklar, L. A., et al. (2012). The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates. Antimicrob. Agents Chemother. 56, 1508-1515. doi: 10.1128/AAC.05706-11
14. Ivanova, A., Batovska, D., Engi, H., Parushev, S., Ocsovszki, I., Kostova, I., et al. (2008). MDR-reversal activity of chalcones. In Vivo 22, 379-384.
15. Ivnitski-Steele, I., Holmes, A. R., Lamping, E., Monk, B. C., Cannon, R. D., and Sklar, L. A. (2009). Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p. Anal. Biochem. 394, 87-91. doi: 10.1016/j.ab.2009.07.001
16. Keniya, M. V., Fleischer, E., Klinger, A., Cannon, R. D., and Monk, B. C. (2015). Inhibitors of the Candida albicans Major Facilitator Superfamily transporter Mdr1p responsible for fluconazole resistance. PLoS ONE 10:e0126350. doi: 10.1371/journal.pone.0126350
17. Konieczny, M. T., Konieczny, W., Pirska, D., Bulakowska, A., Sabisz, M., Skladanowski, A., et al. (2007a). Synthesis of oxathiolone fused chalcones bearing O-aminoalkyl side chain. Comparison of stability of isomeric benzoxathiolones under alkylation reaction conditions. Heterocycles 71, 2595-2615. doi: 10.3987/COM-07-11165
18. Konieczny, M. T., Konieczny, W., Sabisz, M., Skladanowski, A., Wakiec, R., Augustynowicz-Kopec, E., et al. (2007b). Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line. Eur. J. Med. Chem. 42, 729-733. doi: 10.1016/j.ejmech.2006.12.014
19. Konieczny, M. T., Konieczny, W., Sabisz, M., Skladanowski, A., Wakiec, R., Augustynowicz-Kopec, E., et al. (2007c). Synthesis of isomeric, oxathiolone fused chalcones and comparison of their activity toward various microorganisms and human cancer cells line. Chem. Pharm. Bull. 55, 817-820. doi: 10.1248/cpb.55.817
20. Lacka, I., Konieczny, M. T., Bulakowska, A., Rzymowski, T., and Milewski, S. (2011). Antifungal action of the oxathiolone fused chalcone derivative. Mycoses 54, e407-e414. doi: 10.1111/j.1439-0507.2010.01936.x
21. Liu, X. L., Tee, H. W., and Go, M. L. (2008). Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein. Bioorg. Med. Chem. 16, 171-180. doi: 10.1016/j.bmc.2007.10.006
22. López, S. N., Castelli, M. V., Zacchino, S. A., Domiìnguez, J. N., Lobo, G., Charris-Charris, J. et al. (2001). In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorg. Med. Chem. 9, 1999-2013. doi: 10.1016/S0968-0896(01)00116-X
23. Marchetti, O., Moreillon, P., Glauser, M. P., Bille, J., and Sanglard, D. (2000). Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob. Agents Chemother. 44, 2373-2381. doi: 10.1128/AAC.44.9.2373-2381.2000
24. Milewski, S., Mignini, F., and Borowski, E. (1991). Synergistic action of nikkomycin X/Z with azole antifungals on Candida albicans. J. Gen. Microbiol. 137, 2155-2161 doi: 10.1099/00221287-137-9-2155
25. Nowakowska, Z. (2007). A review of anti-infective and anti-inflammatory chalcones. Eur. J. Med. Chem. 42, 125-137. doi: 10.1016/j.ejmech.2006.09.019
26. Odds, F. C. (2003). Synergy, antagonism, and what the chequerboard puts between them. J. Antimicrob. Chemother. 52, 1. doi: 10.1093/jac/dkg301
27. Pfaller, M. A., and Diekema, D. J. (2007). Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20, 133-163. doi: 10.1128/CMR.00029-06
28. Pfaller, M. A. (2012). Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am. J. Med. 125, S3-S13. doi: 10.1016/j.amjmed.2011.11.001
29. Prasad, R., De Wergifosse, P., and Goffeau, A. (1998). Molecular cloning and characterization of a novel gene of Candida albicans, CDR1 conferring multiple resistance to drugs and antifungals. Curr. Genet. 27, 320-329. doi: 10.1007/BF00352101
30. Prasad, R., and Goffeau, A. (2012). Yeast ATP-binding cassette transporters conferring multidrug resistance. Ann. Rev. Microbiol. 66, 37-61. doi: 10.1146/annurev-micro-092611-150111
31. Prasad, R., Panwar, S. L., and Smriti, (2002). Drug resistance in yeasts - an emerging scenario. Adv. Microb. Physiol. 46, 155-201. doi: 10.1016/S0065-2911(02)46004-3
32. Ricardo, E., Costa-de-Oliveira, S., Dias, A. S., Guerra, J., Rodrigues, A. G., and Pina-Vaz, C. (2009). Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes. FEMS Yeast Res. 9, 618-625. doi: 10.1111/j.1567-1364.2009.00504.x
33. Sanglard, D., and Odds, F. C. (2002). Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2, 73-85. doi: 10.1016/S1473-3099(02)00181-0
34. Sharma, A., Chakravarti, B., Gupta, M. P., Siddiqui, J. A., Konwar, R., and Tripathi, R. P. (2010). Synthesis and anti breast cancer activity of biphenyl based chalcones. Bioorg. Med. Chem. 18, 4711-4720. doi: 10.1016/j.bmc.2010.05.015
35. Sharma, M., Manoharlal, R., Shukla, S., Puri, N., Prasad, T., Ambudkar, S. V., et al. (2009). Curcumin modulated efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals. Antimicrob. Agents Chemother. 53, 3256-3265. doi: 10.1128/AAC.01497-08
36. Smriti, Krishnamurthy, S., Dixit, B. L., Gupta, C. M., Milewski, S., and Prasad, R. (2002). ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators. Yeast 19, 303-318. doi: 10.1002/yea.818
37. Srinivasan, A., Lopez-Ribot, J. L., and Ramasubramanian, A. K. (2012). Overcoming antifungal resistance. Drug Discov. Today Technol. 11, 65-71. doi: 10.1016/j.ddtec.2014.02.005
38. Wink, M., Ashour, M. L., and Zaki El-Readi, M. (2012). Secondary metabolites from plants inhibiting ABC transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents. Front. Microbiol. 3:130. doi: 10.3389/fmicb.2012.00130